This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Herman AB , Vrakas CN , Ray M , Kelemen SE , Sweredoski MJ , Moradian A , Haines DS , Autieri MV
FXR1 Is an IL-19-Responsive RNA-Binding Protein that Destabilizes Pro-inflammatory Transcripts in Vascular Smooth Muscle Cells
Cell Rep. 2018 Jul 31;24(5) :1176-1189
PMID: 30067974 URL: https://www.ncbi.nlm.nih.gov/pubmed/30067974
AbstractThis work identifies the fragile-X-related protein (FXR1) as a reciprocal regulator of HuR target transcripts in vascular smooth muscle cells (VSMCs). FXR1 was identified as an HuR-interacting protein by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The HuR-FXR1 interaction is abrogated in RNase-treated extracts, indicating that their association is tethered by mRNAs. FXR1 expression is induced in diseased but not normal arteries. siRNA knockdown of FXR1 increases the abundance and stability of inflammatory mRNAs, while overexpression of FXR1 reduces their abundance and stability. Conditioned media from FXR1 siRNA-treated VSMCs enhance activation of naive VSMCs. RNA EMSA and RIP demonstrate that FXR1 interacts with an ARE and an element in the 3' UTR of TNFalpha. FXR1 expression is increased in VSMCs challenged with the anti-inflammatory cytokine IL-19, and FXR1 is required for IL-19 reduction of HuR. This suggests that FXR1 is an anti-inflammation responsive, HuR counter-regulatory protein that reduces abundance of pro-inflammatory transcripts.
Notes2211-1247 Herman, Allison B Vrakas, Christine N Ray, Mitali Kelemen, Sheri E Sweredoski, Michael J Moradian, Annie Haines, Dale S Autieri, Michael V Journal Article United States Cell Rep. 2018 Jul 31;24(5):1176-1189. doi: 10.1016/j.celrep.2018.07.002.